Baker McKenzie legal advisor to Pareto Securities in Guard Therapeutics' rights issue of approximately SEK 120 million

Guard Therapeutics International has carried out a rights issue of approximately SEK 120 million.

Guard Therapeutics is a Swedish clinical-stage biotechnology company that identifies and develops new therapies for diseases with a large unmet medical need, focusing on different forms of kidney disease. The company’s drug candidates are based on the endogenous protein alpha-1-microglobulin. Guard Therapeutics is listed on Nasdaq First North Growth Market Stockholm.